close
close

Cactus Life Sciences announces the acquisition of nspm and eluSCIDate

nspm’s rare disease expertise and global events prowess expands Cactus Life Sciences’ services amid exciting buy-and-build strategy

PRINCETON, NJ / ACCESS THREAD / April 24, 2024 / Cactus Life Sciences, a leading global scientific communications agency working with leading pharmaceutical and biotechnology companies, today announced that they have acquired nspm and eluSCIdate, two dynamic medical communications and publishing companies headquartered in Meggen, Switzerland with an office in Great Britain.

Cactus Life Sciences with nspm and eluSCIDate
Cactus Life Sciences with nspm and eluSCIDate
logo lockup of nspm and eluSCIDate

Headquartered in Princeton, New Jersey, Cactus Life Sciences was founded in 2010 and is best known for its transformational global business models that deliver the best science, innovation and efficiency. Founded 27 years ago, nspm brings extensive expertise in medical communications, publishing and event management, with a focus on rare diseases. The sister company eluSCIDate was founded in 2020 and focuses on medical and scientific publications, combining extensive experience in medical writing with creative flair to deliver high-quality publications.

This collaboration represents a major step forward in improving service delivery to our biopharmaceutical customers, ensuring a comprehensive and fully integrated global approach to medical communications. And creates a significant employee footprint in the US, UK, Switzerland and Japan.

“As Cactus Life Sciences embarks on its upcoming buy-and-build strategy, we are excited to unveil our first acquisition that shares so many of the same values ​​as CACTUS,” said Oliver Dennis, the new chairman of Cactus Life Sciences. “As we move forward, we look for partnerships that prioritize our people and customers alongside our strategic growth.”

Rare diseases individually affect a small number of people, but collectively affect more than 300 million people worldwide, posing significant challenges for patients and medical professionals. NSPM’s expertise in rare diseases focuses on unmet needs for patients and society. Sabine Stotz, PhD, Managing Director, NSPM, commented: “This strategic alliance is a testament to the shared vision of excellence between Cactus Life Sciences, nspm and eluSCIDate. Together, our goal is to enrich the global landscape of scientific communications, creating an even greater impact on healthcare professionals and the patients they treat.”

Elvira Dsouza, president of Cactus Life Sciences commented: “Cactus Life Sciences stands out for its unwavering commitment to excellence, innovation and future readiness. With a focus on integrating cutting-edge technology, especially AI, we strive to elevate scientific content creation to to contribute to a more accessible, informed, and transformative healthcare landscape.”

About Cactus Life Sciences (cactuslifesciences.com): Cactus Life Sciences is a medical communications company that delivers scientific strategy and content across the healthcare continuum, anywhere in the world – with an emphasis on science, innovation and efficiency. We work with leading healthcare companies to determine the optimal role of medicine and encourage positive behaviors (physician and patient) that improve patient outcomes.

About nspm (www.nspm.com): nspm is a successful and dynamic medical communications company founded in 1997 with offices in Switzerland and the United Kingdom. nspm provides a complete range of medical writing, project management and strategic medical communications solutions for the pharmaceutical and biotechnology industries across a range of therapeutic areas, with an emphasis on rare diseases. Our employees strive to develop high-quality, cost-effective solutions that exceed customer expectations through scientific excellence, professionalism and creativity.

About eluSCIDate (www.eluscidate.com): eluSCIDate is a medical writing agency founded in 2020, specialized in scientific publications and supporting the entire publication process. We use a wealth of experience in medical writing to deliver high quality manuscripts, posters and slides to our clients. At eluSCIDate we are passionate about science and strive to provide clarity in the scientific message. Through effective communication, we work with our customers to ensure their science stands out from the crowd.

Contact details

Laura Perry
VP Strategy and Marketing
(email protected)
7327121005

SOURCE: Life sciences of cacti

.

View the original press release on newswire.com.